Does your latest innovative idea have commercial potential and support cutting-edge technological research? Explore NIH funding options for small businesses at the 16th Annual NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Conference that will be held in Albuquerque, NM on October 21 – 23, 2014. Continue reading
If you are involved with NIH, then chances are you use eRA Commons. In addition to announcing major changes to electronic submission of grant applications here on the Extramural Nexus, did you know we offer listservs targeted to issues related to electronic submission and eRA Commons, as well? Continue reading
ere on the blog we discuss many different aspects of NIH’s research program – policies, funding trends, workforce issues. A few weeks ago, while I was preparing to give the opening talk at the NIH Regional Seminar on Program Funding and Grants Administration, I realized some Rock Talk readers might be interested in learning more about how these topics fit into the big picture of NIH. So, I asked my colleagues to tape this talk, “NIH: The View from 10,000 Feet”, so I could share it with you on the blog …. Continue reading
In these times of tight budgets and rapidly evolving science, we must consider new ways to invest biomedical research dollars to achieve maximum impact—to turn scientific discoveries into better health as swiftly as possible. We do this by thinking strategically about the areas of research that we support, as well as the process by which we fund that research. …. We often hear from investigators at all career stages that they spend a significant portion of their careers writing grant applications, consuming precious time that could otherwise be spent conducting research. …. Continue reading
A question that I hear often from investigators is: are my chances of funding increased or decreased by submitting a multi-PI application? It was seven years ago that NIH implemented the Multiple Principal Investigator Policy to encourage interdisciplinary and team approaches to biomedical research, and give scientists the option to apply with their peers and allow for equal credit for leadership of the research program. While the single-PI model works well, and continues to be the model for most of NIH’s research grants, the multi-PI option recognizes that as health research grows in scale and complexity, scientific teams may better reflect the intellectual and scientific leadership within a given grant application. So, let’s look at some data on how multi-PI applications fare in comparison to single-PI applications. …. Continue reading
A major report on the Physician-Scientist Workforce was presented and discussed at the most recent Advisory Council to the Director (ACD) meeting. It was a highly anticipated follow-up to the Biomedical Workforce report from a couple years earlier. I want to follow-up my earlier post with a closer look at some key points presentation by the Physician-Scientist Workforce (PSW) working group. Continue reading
NIH currently requires use of the fed-wide progress reporting format — known as the RPPR (Research Performance Progress Report) — to submit progress reports for Streamlined Non-competing Award Process (SNAP), fellowship, and multi-year funded awards. In April we opened the RPPR for use for all Type 5 Non-SNAP progress reports in anticipation of an October 2014 requirement for RPPR use.
Now, it’s official — all type 5 non-SNAP progress reports submitted on or after October 17, 2014 need to be submitted through the RPPR module of eRA Commons. …. Continue reading
True or false: iEdison is the newest Apple™ light bulb.
Well, for now at least, false. iEdison – which stands for “interagency Edison” – is a system for reporting inventions resulting from federal funding. iEdison is now part of NIH’s electronic Research Administration (eRA) suite of services, and our new website helps iEdison users access information and resources related to invention reporting. …. Continue reading
No. If you are appealing the initial peer review of your application, then the appeal must be resolved before you submit that application as either a resubmission (A1) or new application (A0).
Looking for more information on NIH’s resubmission policy? Visit our frequently asked questions about resubmission. Continue reading
A resubmission application, also known as an “A1” application, requires a one-page introduction that addresses the comments from the review of the prior A0 application as well as marked changes in the text of the Research Strategy. You are permitted one resubmission of an unfunded application to address reviewer comments, and that resubmission must be submitted to an appropriate due date no longer than 37 months …. Continue reading